InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Krakaris Emmanuel, 董事长兼首席执行官. Officer active across 2 companies, notably Augmedix, Inc.. In total, 5 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €173k. History available since 28 October 2021. The latest transaction was disclosed on 2 October 2024 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Krakaris Emmanuel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
64,748 股@ US$2.35100.0% 占其流量Common StockSEC:0001213900-24-085342:0
9,375 股Common StockSEC:0001213900-24-070862:0
9,375 股Common StockSEC:0001213900-24-044877:0
15,551 股@ US$3.2025.6% 占其流量Common StockSEC:0001213900-21-062044:0
标准退出：2022年2月22日 (T+90)
37,500 股@ US$4.0074.4% 占其流量Common StockSEC:0001213900-21-055925:0
标准退出：2022年1月26日 (T+90)
5 条申报中的 5 条
About Krakaris Emmanuel
Emmanuel Krakaris is the Chairman & CEO and Secretary of Augmedix, Inc. He is responsible for the strategic direction of the company, ensuring its development and compliance. Emmanuel plays a key role in the innovation and enhancement of the services offered by Augmedix.
